UGT1A1 and neutropenia: However, patients homozygous for UGT1A1*28 or *6 or compound heterozygous for UGT1A1*28 and *6 have been reported to have a high incidence of irinotecan‐related toxicity (neutropenia, diarrhea, etc.).26